Trends in anti-HER2 drugs consumption and influencing factors

BackgroundHuman epidermal growth factor receptor 2 (HER2) inhibitors have been approved to treat various cancers with HER2 amplification. The Chinese government has made great efforts to improve the availability and affordability of these drugs. This study aimed to analyze the trends in anti-HER2 dr...

Full description

Bibliographic Details
Main Authors: Jie Liu, Xiaolei Zhang, Biao Wang, Huizhen Dai, Dahai Dou, Wentong Fang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.944071/full